Appointment of Non-Executive Director

RNS Number : 1754K

Life Science REIT PLC

03 May 2022

 

3 May 2022

LEI: 213800RG7JNX7K8F7525

Life Science REIT plc

("Life Science REIT" or the "Company")

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

Life Science REIT (AIM: LABS), the real estate investment trust focused on UK life science properties, is pleased to announce the appointment of Richard Howell as an independent non-executive Director of the Company with effect from today, 3 May 2022. As part of a planned succession process, the Board anticipates that Richard will replace Dr Sally Ann Forsyth OBE in the role of Chair of the Audit & Risk Committee (the "Committee") following his initial induction process and a subsequent RNS announcement will be made on his appointment as Chair of the Committee. In respect to the future rotation of Chair of the Committee, Sally Ann has today been appointed as Sustainability Lead for the Company.

Richard is Chief Financial Officer of Primary Health Properties plc, the FTSE-250 REIT and leading investor in flexible, modern primary healthcare accommodation across the UK and Ireland. He has  over 25 years of commercial property experience within the listed property sector and previously held the role of Finance Director - Joint Ventures at LondonMetric Property plc until March 2017. Richard is a qualified accountant with relevant financial experience.

Claire Boyle, Chair of Life Science REIT plc, comments:

"We are delighted to welcome Richard to the Board as an Independent Non-Executive Director. His high calibre expertise as a CFO, together with his extensive experience in the commercial property sector, will be hugely valuable to the Company, and we look forward to working with him."

Regulatory Disclosures:

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

Richard Howell, and his persons closely associated, does not currently hold any shares in the Company.

Richard Howell (aged 56): holds, or has held, the following current and former directorships in the past five years:

Current Directorships	Previous Directorships in the last five years
Anchor Meadow Limited	AHG (2006) Limited
Carden Medical Investments Limited	Chapeloak Investments Ltd
Chelmsley Associates Limited	Medicx (Verwood) Ltd
Crestdown Limited	Medicx LHF Ltd.
GP Property One Ltd	Medicx LHP Ltd.
GPG No.5 Limited	MXF Properties Otley Limited
Gracemount Medical Centre Limited	MXF Properties Windermere Limited
Health Investments Limited	PHIP (Hoddesdon) Limited
Leighton Health Limited	PHIP (RHL) Limited
Motorstep Limited	PHIP (Sheerness) Limited
MXF (Fakenham) Limited	PHIP CH Limited
MXF Properties Bridlington Limited	PHP (Chandler's Ford) Limited
MXF Properties II Limited	PHP (FRMC) Limited
MXF Properties III Limited	PHP (Portsmouth) Limited
MXF Properties IV Limited	PHP 2013 Holdings Limited
MXF Properties IX Limited	PHP Ashington Limited
MXF Properties OM Group Limited	Primary Health Investment Properties (No 11) Limited
MXF Properties OM Holdings Limited	Primary Health Investment Properties (No.7) Limited
MXF Properties OM Limited	Primary Health Investment Properties (Sutton) Limited
Patientfirst (Burnley) Limited	SPCD (Northwich) Limited
Patientfirst (Hinckley) Limited	SPCD (Shavington) Limited
Patientfirst Partnerships Limited	Wells Farm Property Owners Limited
PHIP (5) Limited	White Horse Centre Limited
PHIP (Chester) Limited	Wincanton Healthcare Limited
PHIP (Milton Keynes) Limited
PHIP (Stourbridge) Limited
PHP (Bingham) Limited
PHP (Ipswich) Limited
PHP (Project Finance) Limited
PHP (Spilsby) Limited
PHP Assetco (2011) Limited
PHP AV Lending Limited
PHP Bond Finance Plc
PHP Cardiff Group Limited
PHP Cardiff Limited
PHP Clinics Limited
PHP Croft Limited
PHP Developments (Cardiff) Limited
PHP Empire Holdings Limited
PHP Epsom Limited
PHP Euro Private Placement Limited
PHP Euro Private Placement ML Limited
PHP Glen Spean Limited
PHP Health Solutions Limited
PHP Healthcare (Holdings) Limited
PHP Healthcare Investments Limited
PHP Investments (2011) Limited
PHP Investments No.1 Limited
PHP Investments No.2 Limited
PHP Liverpool Holding Company Limited
PHP Liverpool Limited
PHP Medical Investments Limited
PHP Medical Properties Limited
PHP Primary Care Developments Limited
PHP Primary Properties (Haymarket) Limited
PHP Primary Properties Limited
PHP Property Management Services Limited
PHP SB Limited
PHP SPV Limited
PHP St. Johns Limited
PHP STL Limited
PHP Tradeco Holdings Limited
PHP Tradeco Limited
Primary Health Investment Properties (No 9) Limited
Primary Health Investment Properties (No. 2) Limited
Primary Health Investment Properties (No. 3) Limited
Primary Health Investment Properties (No.4) Limited
Primary Health Investment Properties (No.6) Limited
Primary Health Investment Properties (No.8) Limited
Primary Health Investment Properties Limited
Primary Health Properties Plc
Primary Medical Property Investments Limited

Further regulatory disclosures:

Other than as disclosed above, there are no further disclosures regarding Richard Howell to be made in accordance with AIM Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies.  

Enquiries:

Link Company Matters Limited (Company Secretary) [e-mail]
Ironstone Asset Management Limited (Investment Adviser) Simon Farnsworth	via Buchanan below
Panmure Gordon (Financial Adviser, Nominated Adviser and Broker) Atholl Tweedie / Sapna Shah / Philip Shields / Chloe Ponsonby	[phone]
Jefferies International Limited - Joint Corporate Broker Tom Yeadon / Andrew Morris / Oliver Nott	[phone]
Buchanan (Financial PR & IR Adviser to the Company) Mark Court / Henry Wilson / Verity Parker [e-mail]	[phone]

Notes to editors

Life Science REIT plc is a property business focused solely on the UK's growing life science sector, specifically targeting opportunities in the "Golden Triangle" research and development hubs of Oxford, Cambridge and London St Pancras. The Company's intention is to become the property provider of choice for life science companies in the UK, whilst enabling shareholders to gain exposure to a specific growth sector.

The objective of the Company's investment policy is focused on capital growth, whilst also providing a growing level of income, by investing primarily in a diversified portfolio of properties that are leased, or intended to be leased, to occupiers operating in the life science sector in the UK.

Life Science REIT joined the AIM market of the London Stock Exchange on 19 November 2021, having raised £350 million in its IPO. Its shares trade under the ticker LABS.

Further information is available at https://lifesciencereit.co.uk

 

END

 

 

BOAQXLFBLELBBBB